米国の外科手術市場:タイプ別(消化器、心臓血管、歯科、美容、泌尿器、眼科、整形外科、耳鼻科、婦人科手術)、チャネル別(医師オフィス、病院、(入院、外来)、ASC)-2027年までの予測US Surgical Procedures Market by Type (Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Gynecologic Surgical Procedures), Channel (Physician Offices, Hospitals, (Inpatient, Outpatient), ASC) - Forecast to 2027 米国の外科手術市場は、2022年の105,814.5千件から2027年には122,881.5千件に達し、予測期間中のCAGRは3.0%と予測されます。この市場の成長は、主にがんの有病率の増加、慢性疾患の増加、医療施設への投資の増加... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー米国の外科手術市場は、2022年の105,814.5千件から2027年には122,881.5千件に達し、予測期間中のCAGRは3.0%と予測されます。この市場の成長は、主にがんの有病率の増加、慢性疾患の増加、医療施設への投資の増加、外科手術の技術的進歩、老年人口の増加などに起因しています。外科手術、麻酔、集中治療技術の進歩により、拡大する高齢者人口のうち外科手術を受ける人の割合が多くなっており、これが米国の外科手術市場の成長を牽引することになります。本レポートでは、米国の外科手術市場をタイプおよびチャネルに基づいて区分しています。タイプに基づいて、米国の外科手術市場は、消化器外科手術、心臓血管外科手術、歯科外科手術、美容外科手術、泌尿器科外科手術、眼科外科手術、整形外科手術、耳鼻科外科手術、産科/婦人科外科手術、およびその他の外科手術に区分される。 2021年には、歯科用外科処置のセグメントがこの市場の最大のシェアを占めました。このセグメントのシェアは、口腔ケアに対する意識の高まり、口腔疾患の有病率の増加、高齢化率の上昇とそれに伴う歯の喪失に起因するものと考えられる。眼科外科処置セグメントは、予測期間中に最も高いCAGRで成長すると推定されます。この分野の高い成長は、緑内障、白内障、糖尿病性網膜症などのさまざまな眼科疾患の有病率が老年人口で上昇し、それに伴って眼病が増加していることに起因していると思われます。 米国の外科手術市場は、チャネルに基づいて、医師オフィス、病院、外来手術センターに区分されます。2021年には、医師オフィスセグメントがこの市場の最大のシェアを占めました。このセグメントの最大シェアは、歯科処置、上部内視鏡検査、結腸鏡検査、鼻形成術、乳房形成術、結石除去術、または血管アクセス関連処置などの低侵襲手術の増加および医師オフィスで行われる手術の多さに起因するものと考えられます。外来手術センターセグメントは、予測期間中に最も高いCAGRで成長すると推定されます。このセグメントのCAGRが最も高いのは、コスト削減の可能性と、患者の間でより良い、より迅速なケアへの需要が高まっていることに起因すると考えられる。 調査対象 このレポートは米国の外科手術市場を分析し、タイプやチャネルなどの様々なセグメントに基づいて、外科手術のボリュームとこの市場の将来の成長可能性を推定することを目的としています。 レポートを購入する理由 レポートでは、確立された企業だけでなく、新規参入者/小規模な企業は、順番に、市場のより重要なシェアを獲得するのに役立つだろう、市場のパルスを測定するために豊かになります。本レポートを購入された企業は、下記の戦略のいずれか、または組み合わせて使用することで、市場での地位を強化することができます。 本レポートでは、以下のポイントについて考察しています。 - 新興技術分析。外科的処置における有利な新興技術の進歩に関する包括的な情報 - 定量的な分析。米国で実行される手術のさまざまな種類の数についての包括的な情報。 目次1 INTRODUCTION 111.1 OBJECTIVES OF THE STUDY 11 1.2 MARKET DEFINITION 11 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 11 1.3 SCOPE OF THE STUDY 12 1.3.1 MARKETS COVERED 12 FIGURE 1 US OUTPATIENT SURGICAL PROCEDURES MARKET 12 1.3.2 YEARS CONSIDERED FOR THE STUDY 12 1.4 STAKEHOLDERS 13 1.5 SUMMARY OF CHANGES 13 1.6 LIMITATIONS 13 2 RESEARCH METHODOLOGY 14 2.1 RESEARCH DATA 14 FIGURE 2 RESEARCH DESIGN 14 2.1.1 SECONDARY DATA 14 2.1.1.1 Key data from secondary sources 15 2.1.2 PRIMARY DATA 16 2.1.2.1 Key data from primary sources 16 2.1.2.2 Key industry insights 17 2.2 MARKET ESTIMATION 17 FIGURE 3 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE US SURGICAL PROCEDURES MARKET (2022–2027) 18 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 19 FIGURE 4 MARKET DATA TRIANGULATION METHODOLOGY 19 2.4 ASSUMPTIONS FOR THE STUDY 20 2.5 METHODOLOGY-RELATED LIMITATIONS 20 3 EXECUTIVE SUMMARY 21 FIGURE 5 US SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 21 FIGURE 6 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 22 FIGURE 7 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 22 FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 23 FIGURE 9 COSMETIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 23 FIGURE 10 UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 24 FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 24 FIGURE 12 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 25 FIGURE 13 ENT SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 25 FIGURE 14 OBSTETRIC/ GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 26 FIGURE 15 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2022 VS. 2027 (THOUSAND PROCEDURES) 26 4 PREMIUM INSIGHTS 28 4.1 US SURGICAL PROCEDURES MARKET OVERVIEW 28 FIGURE 16 GROWTH IN GERIATRIC POPULATION AND RISE IN CHRONIC DISEASES TO DRIVE MARKET GROWTH 28 4.2 US SURGICAL PROCEDURES MARKET, BY TYPE 29 FIGURE 17 DENTAL SURGICAL PROCEDURES SEGMENT TO HOLD THE LARGEST SHARE OF THE US SURGICAL PROCEDURES MARKET IN 2021 29 5 MARKET OVERVIEW 30 5.1 INTRODUCTION 30 5.2 MARKET DYNAMICS 30 FIGURE 18 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30 5.2.1 DRIVERS 31 5.2.1.1 Growing prevalence of cancer requiring surgical treatment 31 FIGURE 19 US: CANCER CASES, BY TYPE, 2020–2040 (THOUSANDS) 31 FIGURE 20 US: NEW CANCER CASES, 2012–2022 (MILLION INDIVIDUALS) 32 5.2.1.2 Growth in geriatric population and rise in chronic diseases 32 FIGURE 21 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 33 5.2.1.3 Technological advancements in surgical procedures 34 TABLE 1 US: RISE IN SURGICAL PROCEDURES 34 FIGURE 22 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION) 35 5.2.2 RESTRAINTS 35 5.2.2.1 Shortage of surgeons 35 5.2.3 OPPORTUNITIES 36 5.2.3.1 Increasing adoption of outpatient surgeries 36 5.2.4 CHALLENGES 36 5.2.4.1 Surgical errors 36 5.2.4.2 Complications associated with surgical procedures 38 TABLE 2 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES 38 6 INDUSTRY INSIGHTS 40 6.1 INTRODUCTION 40 6.2 INDUSTRY TRENDS 40 6.2.1 MINIMALLY INVASIVE SURGERY 40 6.2.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS 41 6.3 REIMBURSEMENT SCENARIO 42 TABLE 3 LIST OF SURGICAL PROCEDURE CODES 43 6.4 IMPACT OF COVID-19 ON THE US SURGICAL PROCEDURES MARKET 44 6.5 TECHNOLOGY ANALYSIS 45 7 US SURGICAL PROCEDURES MARKET, BY TYPE 46 7.1 INTRODUCTION 47 TABLE 4 US: SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2027 (THOUSAND) 47 7.2 DENTAL SURGICAL PROCEDURES 48 7.2.1 INCREASING PREVALENCE OF ORAL DISEASES AND RISING AWARENESS OF DENTAL CARE DRIVE THE GROWTH OF DENTAL SURGICAL PROCEDURES 48 TABLE 5 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 48 7.3 ORTHOPEDIC SURGICAL PROCEDURES 49 7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED ORTHOPEDIC DEVICES WILL INCREASE THE NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES 49 TABLE 6 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 50 7.4 GASTROINTESTINAL SURGICAL PROCEDURES 50 7.4.1 THE INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES IS DRIVING GROWTH IN THIS SEGMENT 50 FIGURE 23 US: STOMACH CANCER INCIDENCE, 2020–2040 (THOUSANDS) 51 TABLE 7 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 52 7.5 OPHTHALMIC SURGICAL PROCEDURES 52 7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY DRIVE DEMAND FOR OPHTHALMIC SURGICAL TREATMENT IN THE US 52 TABLE 8 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 53 7.6 CARDIOVASCULAR SURGICAL PROCEDURES 53 7.6.1 HEART DISEASE IS THE LEADING CAUSE OF DEATH IN THE US 53 TABLE 9 US: NUMBER OF CASES OF CARDIOVASCULAR DISEASES, 2015-2035 (MILLION) 54 FIGURE 24 US: MORTALITY RATE OF CARDIOVASCULAR DISEASES, BY TYPE, 2018 55 TABLE 10 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 55 7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES 56 7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES DRIVES MARKET GROWTH 56 TABLE 11 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 57 7.8 ENT SURGICAL PROCEDURES 57 7.8.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY ARE MAJOR REASONS FOR THE GROWTH OF ENT SURGICAL PROCEDURES 57 TABLE 12 US: ENT SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 58 7.9 COSMETIC SURGICAL PROCEDURES 58 7.9.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES BOOSTS THE ADOPTION OF COSMETIC SURGERIES 58 TABLE 13 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 60 7.10 UROLOGIC SURGICAL PROCEDURES 60 7.10.1 INCREASING INCIDENCE OF DIABETES AND HIGH BLOOD PRESSURE INCREASES THE RISK OF KIDNEY DISEASES 60 TABLE 14 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 61 7.11 OTHER SURGICAL PROCEDURES 61 TABLE 15 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 62 TABLE 16 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 62 TABLE 17 US: INTEGUMENTARY SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 63 8 US SURGICAL PROCEDURES MARKET, BY CHANNEL 64 8.1 INTRODUCTION 65 TABLE 18 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2020–2027 (THOUSAND) 65 8.2 PHYSICIAN OFFICES 65 8.2.1 TECHNOLOGICAL ADVANCES MAKING OFFICE-BASED SURGERY MORE FEASIBLE DRIVE THE MARKET GROWTH 65 8.3 HOSPITALS 66 TABLE 19 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019) 66 TABLE 20 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (THOUSAND) 67 8.3.1 INPATIENT SURGERIES 67 8.3.1.1 Increasing incidences of cardiovascular, neurological, and intestinal disorders are driving growth for this market 67 FIGURE 25 US NATIONAL INPATIENT STAYS, 2016–2018 68 8.3.2 OUTPATIENT SURGERIES 68 8.3.2.1 Convenience and lower cost are major advantages of outpatient surgeries 68 8.4 AMBULATORY SURGERY CENTERS 69 8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS PROPEL THE GROWTH OF THIS SEGMENT 69 9 APPENDIX 71 9.1 DISCUSSION GUIDE 71 9.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 76 9.3 RELATED REPORTS 78 9.4 AUTHOR DETAILS 79
SummaryThe US surgical procedures market is projected to reach 122,881.5 thousand procedures by 2027 from 105,814.5 thousand procedures in 2022, at a CAGR of 3.0% during the forecast period. The growth of this market is mainly attributed to the growing prevalence of cancer, rise in chronic diseases, increased investment in health facilities, technological advancements in surgical procedures and growth in geriatric population. Advances in surgical, anesthetic, and intensive care techniques have led a larger proportion of expanding elderly population to undergo surgical procedures, which will drive the growth of the US surgical procedures market. Table of Contents1 INTRODUCTION 111.1 OBJECTIVES OF THE STUDY 11 1.2 MARKET DEFINITION 11 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 11 1.3 SCOPE OF THE STUDY 12 1.3.1 MARKETS COVERED 12 FIGURE 1 US OUTPATIENT SURGICAL PROCEDURES MARKET 12 1.3.2 YEARS CONSIDERED FOR THE STUDY 12 1.4 STAKEHOLDERS 13 1.5 SUMMARY OF CHANGES 13 1.6 LIMITATIONS 13 2 RESEARCH METHODOLOGY 14 2.1 RESEARCH DATA 14 FIGURE 2 RESEARCH DESIGN 14 2.1.1 SECONDARY DATA 14 2.1.1.1 Key data from secondary sources 15 2.1.2 PRIMARY DATA 16 2.1.2.1 Key data from primary sources 16 2.1.2.2 Key industry insights 17 2.2 MARKET ESTIMATION 17 FIGURE 3 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE US SURGICAL PROCEDURES MARKET (2022–2027) 18 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 19 FIGURE 4 MARKET DATA TRIANGULATION METHODOLOGY 19 2.4 ASSUMPTIONS FOR THE STUDY 20 2.5 METHODOLOGY-RELATED LIMITATIONS 20 3 EXECUTIVE SUMMARY 21 FIGURE 5 US SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 21 FIGURE 6 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 22 FIGURE 7 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 22 FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 23 FIGURE 9 COSMETIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 23 FIGURE 10 UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 24 FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 24 FIGURE 12 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 25 FIGURE 13 ENT SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 25 FIGURE 14 OBSTETRIC/ GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 26 FIGURE 15 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2022 VS. 2027 (THOUSAND PROCEDURES) 26 4 PREMIUM INSIGHTS 28 4.1 US SURGICAL PROCEDURES MARKET OVERVIEW 28 FIGURE 16 GROWTH IN GERIATRIC POPULATION AND RISE IN CHRONIC DISEASES TO DRIVE MARKET GROWTH 28 4.2 US SURGICAL PROCEDURES MARKET, BY TYPE 29 FIGURE 17 DENTAL SURGICAL PROCEDURES SEGMENT TO HOLD THE LARGEST SHARE OF THE US SURGICAL PROCEDURES MARKET IN 2021 29 5 MARKET OVERVIEW 30 5.1 INTRODUCTION 30 5.2 MARKET DYNAMICS 30 FIGURE 18 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30 5.2.1 DRIVERS 31 5.2.1.1 Growing prevalence of cancer requiring surgical treatment 31 FIGURE 19 US: CANCER CASES, BY TYPE, 2020–2040 (THOUSANDS) 31 FIGURE 20 US: NEW CANCER CASES, 2012–2022 (MILLION INDIVIDUALS) 32 5.2.1.2 Growth in geriatric population and rise in chronic diseases 32 FIGURE 21 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 33 5.2.1.3 Technological advancements in surgical procedures 34 TABLE 1 US: RISE IN SURGICAL PROCEDURES 34 FIGURE 22 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION) 35 5.2.2 RESTRAINTS 35 5.2.2.1 Shortage of surgeons 35 5.2.3 OPPORTUNITIES 36 5.2.3.1 Increasing adoption of outpatient surgeries 36 5.2.4 CHALLENGES 36 5.2.4.1 Surgical errors 36 5.2.4.2 Complications associated with surgical procedures 38 TABLE 2 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES 38 6 INDUSTRY INSIGHTS 40 6.1 INTRODUCTION 40 6.2 INDUSTRY TRENDS 40 6.2.1 MINIMALLY INVASIVE SURGERY 40 6.2.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS 41 6.3 REIMBURSEMENT SCENARIO 42 TABLE 3 LIST OF SURGICAL PROCEDURE CODES 43 6.4 IMPACT OF COVID-19 ON THE US SURGICAL PROCEDURES MARKET 44 6.5 TECHNOLOGY ANALYSIS 45 7 US SURGICAL PROCEDURES MARKET, BY TYPE 46 7.1 INTRODUCTION 47 TABLE 4 US: SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2027 (THOUSAND) 47 7.2 DENTAL SURGICAL PROCEDURES 48 7.2.1 INCREASING PREVALENCE OF ORAL DISEASES AND RISING AWARENESS OF DENTAL CARE DRIVE THE GROWTH OF DENTAL SURGICAL PROCEDURES 48 TABLE 5 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 48 7.3 ORTHOPEDIC SURGICAL PROCEDURES 49 7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED ORTHOPEDIC DEVICES WILL INCREASE THE NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES 49 TABLE 6 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 50 7.4 GASTROINTESTINAL SURGICAL PROCEDURES 50 7.4.1 THE INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES IS DRIVING GROWTH IN THIS SEGMENT 50 FIGURE 23 US: STOMACH CANCER INCIDENCE, 2020–2040 (THOUSANDS) 51 TABLE 7 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 52 7.5 OPHTHALMIC SURGICAL PROCEDURES 52 7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY DRIVE DEMAND FOR OPHTHALMIC SURGICAL TREATMENT IN THE US 52 TABLE 8 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 53 7.6 CARDIOVASCULAR SURGICAL PROCEDURES 53 7.6.1 HEART DISEASE IS THE LEADING CAUSE OF DEATH IN THE US 53 TABLE 9 US: NUMBER OF CASES OF CARDIOVASCULAR DISEASES, 2015-2035 (MILLION) 54 FIGURE 24 US: MORTALITY RATE OF CARDIOVASCULAR DISEASES, BY TYPE, 2018 55 TABLE 10 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 55 7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES 56 7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES DRIVES MARKET GROWTH 56 TABLE 11 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 57 7.8 ENT SURGICAL PROCEDURES 57 7.8.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY ARE MAJOR REASONS FOR THE GROWTH OF ENT SURGICAL PROCEDURES 57 TABLE 12 US: ENT SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 58 7.9 COSMETIC SURGICAL PROCEDURES 58 7.9.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES BOOSTS THE ADOPTION OF COSMETIC SURGERIES 58 TABLE 13 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 60 7.10 UROLOGIC SURGICAL PROCEDURES 60 7.10.1 INCREASING INCIDENCE OF DIABETES AND HIGH BLOOD PRESSURE INCREASES THE RISK OF KIDNEY DISEASES 60 TABLE 14 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 61 7.11 OTHER SURGICAL PROCEDURES 61 TABLE 15 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 62 TABLE 16 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 62 TABLE 17 US: INTEGUMENTARY SYSTEM SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 63 8 US SURGICAL PROCEDURES MARKET, BY CHANNEL 64 8.1 INTRODUCTION 65 TABLE 18 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2020–2027 (THOUSAND) 65 8.2 PHYSICIAN OFFICES 65 8.2.1 TECHNOLOGICAL ADVANCES MAKING OFFICE-BASED SURGERY MORE FEASIBLE DRIVE THE MARKET GROWTH 65 8.3 HOSPITALS 66 TABLE 19 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019) 66 TABLE 20 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (THOUSAND) 67 8.3.1 INPATIENT SURGERIES 67 8.3.1.1 Increasing incidences of cardiovascular, neurological, and intestinal disorders are driving growth for this market 67 FIGURE 25 US NATIONAL INPATIENT STAYS, 2016–2018 68 8.3.2 OUTPATIENT SURGERIES 68 8.3.2.1 Convenience and lower cost are major advantages of outpatient surgeries 68 8.4 AMBULATORY SURGERY CENTERS 69 8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS PROPEL THE GROWTH OF THIS SEGMENT 69 9 APPENDIX 71 9.1 DISCUSSION GUIDE 71 9.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 76 9.3 RELATED REPORTS 78 9.4 AUTHOR DETAILS 79
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(通信回線)の最新刊レポート
MarketsandMarkets社の通信回線分野での最新刊レポート
本レポートと同じKEY WORD(surgical)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |